Evidence map›Paper›PMID 38951637›Full record

ArticleNature medicine2024

Author Correction: Prediction of recurrence risk in endometrial cancer with multimodal deep learning.

Sarah Volinsky-Fremond, Nanda Horeweg, Sonali Andani, Jurriaan Barkey Wolf, Maxime W Lafarge, Cor D de Kroon, Gitte Ørtoft, Estrid Høgdall, Jouke Dijkstra, Jan J Jobsen and 15 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Sarah Volinsky-FremondDepartment of Pathology, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-8195-5735
Nanda HorewegDepartment of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-8581-4753
Sonali AndaniDepartment of Computer Science, ETH Zurich, Zurich, Switzerland.
Jurriaan Barkey WolfDepartment of Pathology, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-7811-0280
Maxime W LafargeDepartment of Pathology and Molecular Pathology, University Hospital, University of Zurich, Zurich, Switzerland.
Cor D de KroonDepartment of Gynecology and Obstetrics, Leiden University Medical Center, Leiden, The Netherlands.
Gitte ØrtoftDepartment of Gynecology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Estrid HøgdallDepartment of Pathology, Herlev University Hospital, Herlev, Denmark.
Jouke DijkstraDepartment of Radiology, Leiden University Medical Center, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-8666-3731
Jan J JobsenDepartment of Radiation Oncology, Medisch Spectrum Twente, Enschede, The Netherlands.
Ludy C H W LutgensMaastricht Radiation Oncology, MAASTRO, Maastricht, The Netherlands.
Melanie E PowellDepartment of Clinical Oncology, Barts Health NHS Trust, London, UK.
Linda R MileshkinDepartment of Medical Oncology, Peter MacCallum Cancer Center, Melbourne, Victoria, Australia.ORCID http://orcid.org/0000-0001-6826-6014
Helen MackayDepartment of Medical Oncology and Hematology, Odette Cancer Center Sunnybrook Health Sciences Center, Toronto, Ontario, Canada.
Alexandra LearyDepartment Medical Oncology, Gustave Roussy Institute, Villejuif, France.
Dionyssios KatsarosDepartment of Surgical Sciences, Gynecologic Oncology, Città della Salute and S Anna Hospital, University of Turin, Turin, Italy.
Hans W NijmanDepartment of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Stephanie M de BoerDepartment of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Remi A NoutDepartment of Radiotherapy, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Marco de BruynDepartment of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.ORCID http://orcid.org/0000-0001-9819-9131
David ChurchWellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
Vincent T H B M SmitDepartment of Pathology, Leiden University Medical Center, Leiden, The Netherlands.
Carien L CreutzbergDepartment of Radiation Oncology, Leiden University Medical Center, Leiden, The Netherlands.
Viktor H Koelzer *Department of Pathology and Molecular Pathology, University Hospital, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-9206-4885
Tjalling Bosse *Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands. t.bosse@lumc.nl.ORCID http://orcid.org/0000-0002-6881-8437

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID38951637
PMCPMC11259555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.